Form Health, MD-Led Platform

Form Health is a virtual obesity medicine practice founded by physicians who trained in endocrinology and internal medicine with a focus on the chronic disease management of obesity. Rather than positioning itself as a consumer subscription service, Form Health operates as a specialty medical clinic that bills insurance — a meaningful distinction in a GLP-1 telehealth market dominated by cash-pay platforms. Every patient is cared for by an American Board of Obesity Medicine-certified clinician, supported by registered dietitians and advanced practice providers who work as a coordinated team. This mirrors the care model of the best in-person academic obesity medicine programs, delivered through telehealth. The integration of registered dietitians into the primary care team — not as optional coaching add-ons but as core clinical staff — reflects Form Health''s view that nutritional counseling is medical treatment, not a wellness service. Form Health accepts most major commercial insurance plans and Medicare for clinical visits, labs, and medications. For covered patients, out-of-pocket costs are limited to standard specialist copays and deductibles — a significant financial advantage over program-fee platforms like Calibrate, which charge $199/month on top of medication costs regardless of insurance status. Self-pay patients pay $299/month for the full program, which includes all clinician and dietitian visits plus unlimited messaging. The company has developed employer-facing offerings with predictable, transparent pricing for self-insured employer health plans, positioning itself as a value-based alternative to unmanaged GLP-1 prescribing. In early 2026, Form Health was named a select telehealth partner for both Eli Lilly''s LillyDirect and Novo Nordisk''s NovoCare platforms, giving its patients access to manufacturer-direct GLP-1 pricing programs. Form Health is best understood as the telehealth equivalent of an in-person obesity medicine subspecialty clinic. For patients whose insurance covers specialist visits, it delivers a level of clinical depth and coordination that is difficult to replicate at lower-cost platforms — and does so at comparable or lower net cost to the patient. meaningful distinction in a GLP-1 telehealth market dominated by cash-pay platforms. Every patient is cared for by an American Board of Obesity Medicine-certified clinician, supported by registered dietitians and advanced practice providers who work as a coordinated team. This mirrors the care model of the best in-person academic obesity medicine programs, delivered through telehealth. The integration of registered dietitians into the primary care team — not as optional coaching add-ons but as core clinical staff — reflects Form Health''s view that nutritional counseling is medical treatment, not a wellness service. Form Health accepts most major commercial insurance plans and Medicare for clinical visits, labs, and medications. For covered patients, out-of-pocket costs are limited to standard specialist copays and deductibles — a significant financial advantage over program-fee platforms like Calibrate, which charge $199/month on top of medication costs regardless of insurance status. Self-pay patients pay $299/month for the full program, which includes all clinician and dietitian visits plus unlimited messaging. The company has developed employer-facing offerings with predictable, transparent pricing for self-insured employer health plans, positioning itself as a value-based alternative to unmanaged GLP-1 prescribing. In early 2026, Form Health was named a select telehealth partner for both Eli Lilly''s LillyDirect and Novo Nordisk''s NovoCare platforms, giving its patients access to manufacturer-direct GLP-1 pricing programs. Form Health is best understood as the telehealth equivalent of an in-person obesity medicine subspecialty clinic. For patients whose insurance covers specialist visits, it delivers a level of clinical depth and coordination that is difficult to replicate at lower-cost platforms — and does so at comparable or lower net cost to the patient.